@Phil_Lewis_ For those looking to better themselves now that the ‘pandemic is over’ please take a look at Tollovid. Same 3CLpro inhibitor mechanism Pfizer’s Paxlovid, but natural dietary supplement. Data in acute and LongCOVID $TOMDF
@EricTopol@TheLancet Great article. We all know ‘Long COVID’ isn’t really a condition and that the real question is what are the cardiovascular and inflammation cellular/molecular underpinnings that manifest themselves as Long COVID and how can we intervene against those. That’s where we need to /1
@EricTopol@TheLancet spend a lot more time looking at those who recover more quickly from ‘Long COVID’ than those that don’t. We need biomarkers to be studied intensely during the early phases of COVID and recovery. Most of the vaccine side effects are also COVID side effects, so we have a huge /2
@EricTopol@TheLancet population with which to gather these data. I think this is urgently needed to prevent the longer term consequences that vague ‘Long COVID’ diagnoses are likely masking. The tools are there, we need to look. Diagnostics/biomarkers have never been more important to identify/3